Athena Global Technologies Reports FY26 Results, Restructures Healthcare Vertical

TECHNOLOGY
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Athena Global Technologies Reports FY26 Results, Restructures Healthcare Vertical

Athena Global Technologies announced its FY 2025-26 results, showing a narrowed consolidated net loss of Rs 13.32 crore. The company completed a strategic restructuring of its healthcare vertical, acquiring 100% of MedleyMed Healthcare Solutions. No dividend has been recommended due to insufficient profits, as standalone losses widened to Rs 39.70 crore.

Athena Global Technologies FY26 Results and Restructuring Update

Consolidated Net Loss: Rs 13.32 Crore
Standalone Net Loss: Rs 39.70 Crore

Reader Takeaway: Consolidated losses narrowed, but standalone losses spiked alongside a strategic consolidation of the healthcare business.

What just happened

Athena Global Technologies has filed its annual results for FY 2025-26, reporting a consolidated net loss of Rs 13.32 crore, an improvement over the Rs 20.14 crore loss in the previous year. However, the company's standalone performance saw a sharp decline, with net losses increasing to Rs 39.70 crore compared to Rs 14.12 crore in FY 2024-25. The company also confirmed its 34th Annual General Meeting will be held on September 30, 2026.

Why this matters

The company underwent a major restructuring of its healthcare vertical on March 31, 2026. It divested its stake in Medley Medical Solutions and acquired 100% of MedleyMed Healthcare Solutions. This move is designed to unify its digital healthcare operations—covering B2B and B2C medicine delivery and virtual care—under one roof to enhance governance and capital efficiency.

Risks to watch

Investors should closely track the widening standalone loss and the lack of dividends, which the board cited as a result of inadequate profits. The discrepancy between improved consolidated figures and weakening standalone performance remains a primary point of concern for retail shareholders.

What to track next

The focus will be on the post-restructuring operational performance of the healthcare division in the coming quarters. Shareholders will also look for management updates during the upcoming AGM on September 30, 2026, regarding efforts to stem standalone losses and improve future profitability.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.